相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。[F-18] fallypride characterization of striatal and extrastriatal D-2/3 receptors in Parkinson's disease
Adam J. Stark et al.
NEUROIMAGE-CLINICAL (2018)
Habitual exercisers versus sedentary subjects with Parkinson's Disease: Multimodal PET and fMRI study
Matthew A. Sacheli et al.
MOVEMENT DISORDERS (2018)
A revisit to quantitative PET with 18F-FDOPA of high specific activity using a high-resolution condition in view of application to regenerative therapy
Go Akamatsu et al.
ANNALS OF NUCLEAR MEDICINE (2017)
Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy
Alexander M. Lopez et al.
SEMINARS IN NEUROLOGY (2017)
Adenosine A1 receptors measured with 11C-MPDX PET in early Parkinson's disease
Masahiro Mishina et al.
SYNAPSE (2017)
Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients
Marios Politis et al.
NEUROIMAGE-CLINICAL (2017)
FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study
Sven Hammesfahr et al.
NEURODEGENERATIVE DISEASES (2016)
Dopamine receptors - IUPHAR Review 13
Jean-Martin Beaulieu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Agonist-induced down-regulation of AMPA receptors in oligodendrocyte progenitors
Shireen Hossain et al.
NEUROPHARMACOLOGY (2014)
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
Flora Mela et al.
NEUROBIOLOGY OF DISEASE (2012)
[18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism
Sabine Hellwig et al.
NEUROLOGY (2012)
Diagnostic Accuracy of Combined FP-CIT, IBZM, and MIBG Scintigraphy in the Differential Diagnosis of Degenerative Parkinsonism: A Multidimensional Statistical Approach
Martin Suedmeyer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Dopamine D2-receptors in human narcolepsy: a SPECT study with 123 I-IBZM
C. Hublin et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Cortical and Subcortical Patterns of I-123 Iodobenzamide SPECT in Striatal D2 Receptor Parkinsonisms
Paloma Pifarre et al.
CLINICAL NUCLEAR MEDICINE (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy
Wey-Yil Lin et al.
NUCLEAR MEDICINE COMMUNICATIONS (2010)
A Multitracer Dopaminergic PET Study of Young-Onset Parkinsonian Patients With and Without Parkin Gene Mutations
Maria-Joao Ribeiro et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Regional Analysis of Age-Related Decline in Dopamine Transporters and Dopamine D2-Like Receptors in Human Striatum
Kenji Ishibashi et al.
SYNAPSE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease
Nobukatsu Sawamoto et al.
BRAIN (2008)
Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease:: an [123I]IBZM and [123I]FP-CIT SPECT study
C. C. P. Verstappen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome
S. Hesse et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: The contribution of expectation
Antonio P. Strafella et al.
NEUROIMAGE (2006)
Molecular imaging of the dopaminergic system and its association with human cognitive function
VL Cropley et al.
BIOLOGICAL PSYCHIATRY (2006)
Corticostriatal functional interactions in Parkinson's disease:: a rTMS/[11C]raclopride PET study
AP Strafella et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Function of sigma1 receptors in Parkinson's disease
M Mishina et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism
M Nakagawa et al.
ANNALS OF NUCLEAR MEDICINE (2005)
Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes:: study on 72 patients
M Plotkin et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
The doparnine D2 receptor ligand 18F-desmethoxyfallypride:: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism
M Schreckenberger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Camparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
K Seppi et al.
MOVEMENT DISORDERS (2004)
Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease - A positron emission tomographic study
S Thobois et al.
ARCHIVES OF NEUROLOGY (2004)
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism
C Scherfler et al.
BRAIN (2004)
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
J Horvath et al.
MOVEMENT DISORDERS (2004)
Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans
R Hilker et al.
MOVEMENT DISORDERS (2003)
Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography
C Oyanagi et al.
JOURNAL OF NEUROIMAGING (2002)
Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study
M Ghaemi et al.
MOVEMENT DISORDERS (2002)
Steele-Richardson-Olszewski syndrome:: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo:: 123IBZM SPECT and MRI study
G Arnold et al.
MOVEMENT DISORDERS (2002)
Combination of dopamine transporter and D2 receptor SPELT in the diagnostic evaluation of PD, MSA, and PSP
YJ Kim et al.
MOVEMENT DISORDERS (2002)
Quantitative analysis of striatal dopamine D2 receptors with 123I-iodolisuride SPECT in degenerative extrapyramidal diseases
C Prunier et al.
NUCLEAR MEDICINE COMMUNICATIONS (2001)